Interdisciplinary CardioVascular and Thoracic Surgery,
Год журнала:
2024,
Номер
38(5)
Опубликована: Май 1, 2024
Ascending
aorta
(AA)
dilatation
in
patients
with
bicuspid
aortic
valve
(AV)
is
related
both
to
genetic
and
haemodynamic
factors.
The
aim
of
this
study
compare
late
progression
AA
AV
undergoing
surgical
replacement
(SAVR)
versus
transcatheter
implantation
(TAVI).
Catheterization and Cardiovascular Interventions,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 24, 2025
ABSTRACT
Transfemoral
transcatheter
aortic
valve
Replacement
(TAVR)
has
become
the
standard
therapy
for
patients
with
severe
stenosis
in
over
75
years
old
Europe
or
65
United
States,
regardless
of
surgical
risk.
Furthermore,
iterations
existing
valves
(TAVs),
as
well
devices
novel
concepts,
have
provided
substantial
improvements
respect
to
limitations
previous‐generation
devices.
Hence,
treatment
a
broader
spectrum
feasible,
and
sophisticated
selection
appropriate
TAV
tailored
patients'
anatomy
comorbidities
is
now
possible.
Anatomy,
patient
characteristics,
operator
experience
must
all
inform
proper
device
selection.
This
review
describes
features
performance
current
generation
TAVs
aim
providing
practical
approach
clinicians
when
selecting
specific
patient.
Clinical Research in Cardiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 10, 2025
Heavy
calcifications
in
severe
aortic
stenosis
(AS)
pose
a
major
challenge
patients
undergoing
transcatheter
valve
replacement
(TAVR).
Only
few
studies
have
addressed
the
performance
of
different
heart
valves
(THV)
this
subgroup
patients.
We
aimed
to
investigate
outcomes
self-expanding
Medtronic
CoreValve
Evolut
frame
and
balloon-expandable
Edwards
SAPIEN-3/3
Ultra
THV
challenging
patient
population.
This
was
multicenter
registry
including
total
1513
with
heavily
calcified
AS
TAVR.
The
primary
endpoint
incidence
degree
paravalvular
leak
(PVL)
after
Secondary
endpoints
were
post-implant
hemodynamics
as
well
clinical
according
VARC-3
definitions.
R
but
not
PRO
showed
significantly
higher
rates
PVL
compared
(44.8%
vs.
29.5%
for
mild
PVL,
p
<
0.001),
while
there
no
significant
difference
≥
moderate
between
both
groups
(p
=
0.399).
superior
group.
These
findings
confirmed
propensity
score-matched
analysis.
There
differences
regarding
short-term
permanent
pacemaker
implantation
all-cause
mortality
three
groups.
In
severely
AS,
lower
than
R.
platform
had
system.
Journal of Cardiovascular Development and Disease,
Год журнала:
2023,
Номер
10(5), С. 187 - 187
Опубликована: Апрель 23, 2023
Valve-in-valve
(ViV)
transcatheter
aortic
valve
replacement
(TAVR)
is
emerging
as
an
effective
treatment
for
patients
with
symptomatically
failing
bioprosthetic
valves
and
a
high
prohibitive
surgical
risk;
longer
life
expectancy
has
led
to
higher
demand
these
reinterventions
due
the
increased
possibilities
of
outliving
valve’s
durability.
Coronary
obstruction
most
feared
complication
valve-in-valve
TAVR;
it
rare
but
life-threatening
occurs
frequently
at
left
coronary
artery
ostium.
Accurate
pre-procedural
planning,
mainly
based
on
cardiac
computed
tomography,
crucial
determining
feasibility
ViV
TAVR
assessing
anticipated
risk
eventual
need
protection
measures.
Intraprocedurally,
root
selective
angiography
are
useful
evaluating
anatomic
relationship
between
ostia;
transesophageal
echocardiographic
real-time
monitoring
flow
color
Doppler
pulsed-wave
valuable
tool
that
allows
determination
patency
detection
asymptomatic
obstructions.
Because
developing
delayed
obstruction,
close
postprocedural
obstructions
advisable.
CT
simulations
TAVR,
3D
printing
models,
fusion
imaging
represent
future
directions
may
help
provide
personalized
lifetime
strategy
tailored
approach
each
patient,
potentially
minimizing
complications
improving
outcomes.
Journal of Cardiovascular Development and Disease,
Год журнала:
2023,
Номер
10(6), С. 244 - 244
Опубликована: Май 31, 2023
Surgical
mortality
risk
scores,
even
if
not
properly
designed
and
rarely
tested
in
the
transcatheter
aortic
valve
implantation
(TAVI)
setting,
still
guide
heart
team
managing
significant
stenosis.After
splitting
1763
consecutive
patients
retrospectively
based
on
their
thresholds,
composite
endpoint
early
safety
(ES)
was
adjudicated
according
to
Valve
Academic
Research
Consortium
(VARC)-2
-3
consensus
documents.ES
incidence
higher
VARC-2
rather
than
VARC-3
defined.
Despite
only
showing
ES
had
significantly
lower
absolute
values
of
all
three
main
these
last
failed
foresee
both
intermediate-risk
patients.
The
receiver
operating
characteristic
analysis
also
showed
a
correlation,
but
with
poor
diagnostic
accuracy,
among
scores
ES;
moreover,
absence
low-osmolar
contrast
media
administration
were
identified
as
independent
predictors
1-year
ES,
respectively.
Finally,
single
complication
included
definition
could
affect
mortality.Currently,
most
used
do
have
adequate
accuracy
predicting
after
TAVI.
VARC-2,
instead
VARC-3,
is
an
predictor
mortality.
EuroIntervention,
Год журнала:
2023,
Номер
20(1), С. 95 - 103
Опубликована: Дек. 29, 2023
Midterm
comparative
analyses
of
the
latest
iterations
most
used
Evolut
and
SAPIEN
platforms
for
transcatheter
aortic
valve
implantation
(TAVI)
are
lacking.